Journal of Pregnancy and Neonatal Medicine

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Mini Review - Journal of Pregnancy and Neonatal Medicine (2024) Volume 8, Issue 2

Immune tolerance and pregnancy: Navigating the maternal-fetal interface

Kathrin Edwards *

Department of Obstetrics and Gynecology, University Hospital of Ioannina, Greece

*Corresponding Author:
Kathrin Edwards
Department of Obstetrics and Gynecology, University Hospital of Ioannina, Greece
E-mail: Edwards@gmail.com

Received: 25-Mar-2024, Manuscript No. AAPNM-24-132378; Editor assigned: 26-Mar-2024, PreQC No. AAPNM-24-132378(PQ); Reviewed: 09-Apr-2024, QC No. AAPNM-24-132378; Revised: 15-Apr-2024, Manuscript No. AAPNM-24-132378(R); Published: 22-Apr-2024, DOI: 10.35841/aapnm-8.2.195

Citation: : Edwards K. Immune tolerance and pregnancy: Navigating the maternal-fetal interface. J Preg Neonatal Med. 2024;8(2):195

Visit for more related articles at Journal of Pregnancy and Neonatal Medicine

Introduction

Pregnancy represents a unique immunological challenge as the maternal immune system must navigate the delicate balance between protecting the mother from pathogens and tolerating the semi-allogeneic fetus. Immune tolerance at the maternal-fetal interface is crucial for ensuring successful pregnancy outcomes by preventing maternal immune rejection of the fetus. In this essay, we explore the intricate mechanisms of immune tolerance during pregnancy and its implications for maternal and fetal health [1].

The maternal-fetal interface, comprised of the placenta and decidua, serves as the epicenter of immunological interactions between the mother and the developing fetus. This dynamic interface facilitates nutrient and gas exchange while preventing maternal immune rejection of the fetus. Specialized immune cells, including regulatory T cells (Tregs), uterine natural killer (uNK) cells, and macrophages, populate the maternal-fetal interface and orchestrate immune tolerance mechanisms [2].

Immune tolerance during pregnancy is a fascinating phenomenon crucial for ensuring the successful development of the fetus while maintaining maternal health. Navigating the maternal-fetal interface involves a delicate balance of immune responses to accommodate the semi-allogeneic fetus, prevent rejection, and protect against pathogens [3].

At the maternal-fetal interface, the placenta plays a central role in mediating immune interactions. Specialized immune cells such as regulatory T cells (Tregs), uterine natural killer (uNK) cells, and macrophages create an immunotolerant microenvironment that supports fetal growth and development. Tregs, in particular, are pivotal in maintaining immune tolerance by suppressing maternal immune responses against fetal antigens. This suppression helps prevent the maternal immune system from recognizing fetal tissues as foreign and mounting an immune response against them [4].

Moreover, uNK cells contribute to placental development and vascular remodeling, ensuring optimal blood flow to the fetus. This vascular remodeling is crucial for providing the fetus with nutrients and oxygen essential for its growth and development. Additionally, macrophages at the maternal-fetal interface contribute to tissue remodeling and immune regulation, further supporting a tolerant environment conducive to fetal development [5].

The establishment of immune tolerance during pregnancy involves various mechanisms. Hormonal changes, such as increased levels of estrogen and progesterone, modulate immune cell function and cytokine production, promoting an anti-inflammatory environment. Immune checkpoint molecules like programmed cell death protein 1 (PD-1) and its ligands help maintain immune homeostasis by inhibiting excessive immune activation [6].

Tregs play a central role in maintaining immune tolerance by suppressing maternal immune responses against fetal antigens. Additionally, uNK cells promote placental development and vascular remodeling, ensuring adequate blood flow to the fetus. Immune tolerance during pregnancy is established through a series of complex mechanisms aimed at preventing maternal immune rejection of the fetus [7].

One key mechanism involves the induction of Tregs, a specialized subset of T cells with immunosuppressive properties. Tregs play a crucial role in modulating maternal immune responses and promoting an anti-inflammatory microenvironment at the maternal-fetal interface. Furthermore, the placenta acts as a physical barrier, preventing direct contact between maternal and fetal immune cells and minimizing the risk of immune rejection. Additionally, immune checkpoint molecules, such as programmed cell death protein 1 (PD-1) and its ligands, help to maintain immune homeostasis by inhibiting excessive immune activation [8].

Dysregulation of immune tolerance mechanisms can lead to pregnancy complications, including miscarriage, preeclampsia, and preterm birth. For example, inadequate immune tolerance may result in maternal rejection of the fetus, leading to placental dysfunction and intrauterine growth restriction. Conversely, excessive immune activation may predispose pregnant individuals to autoimmune disorders or increase the risk of maternal-fetal infections. Thus, maintaining a delicate balance between immune tolerance and defense is essential for ensuring optimal pregnancy outcomes [

Environmental factors, such as maternal infections, stress, and exposure to pollutants, can influence immune tolerance mechanisms during pregnancy and impact maternal and fetal health. Maternal infections with viral, bacterial, or parasitic pathogens can trigger inflammatory responses that disrupt immune tolerance mechanisms and increase the risk of adverse pregnancy outcomes. Similarly, maternal stress or exposure to environmental toxins can alter hormone levels and immune cell function, further exacerbating immune dysregulation during pregnancy. Understanding the interplay between environmental factors and immune tolerance is crucial for identifying strategies to mitigate the impact of external stressors on pregnancy health [10].

Conclusion

Immune tolerance at the maternal-fetal interface is essential for ensuring successful pregnancy outcomes by preventing maternal immune rejection of the fetus. The intricate mechanisms underlying immune tolerance during pregnancy involve a delicate balance between immune activation and suppression. Understanding these mechanisms provides valuable insights into the pathogenesis of pregnancy complications and informs strategies to optimize maternal and fetal health outcomes. By navigating the complexities of immune tolerance and pregnancy, we can pave the way for innovative approaches to pregnancy care and intervention strategies aimed at promoting healthy pregnancies.

References

  1. Moldenhauer LM, Hull ML, Foyle KL, et al. Immune–Metabolic Interactions and T Cell Tolerance in Pregnancy. J Immunol. 2022;209(8):1426-36.

    2. Indexed at, Google Scholar, Cross Ref

  2. Valencia?Ortega J, Saucedo R, Pena?Cano MI, et al. Immune tolerance at the maternal?placental interface in healthy pregnancy and pre?eclampsia. J Obstet Gynaecol Res. 2020;46(7):1067-76.

    3. Indexed at, Google Scholar, Cross Ref

  3. True H, Blanton M, Sureshchandra S, et al. Monocytes and macrophages in pregnancy: The good, the bad, and the ugly. Immunol Rev. 2022;308(1):77-92.

    4. Indexed at, Google Scholar, Cross Ref

  4. Ta?ska K, Gietka-Czernel M, Glinicki P, et al. Thyroid autoimmunity and its negative impact on female fertility and maternal pregnancy outcomes. Front Endocrinol (Lausanne). 2023;13:1049665.

    5. Indexed at, Google Scholar, Cross Ref

  5. Borgers JS, Heimovaara JH, Cardonick E, et al. Immunotherapy for cancer treatment during pregnancy. Lancet Oncol. 2021;22(12):550-61.

    6. Indexed at, Google Scholar, Cross Ref

  6. Abu-Raya B, Michalski C, Sadarangani M, et al. Maternal immunological adaptation during normal pregnancy. Front Immunol. 2020;11:575197.

    7. Indexed at, Google Scholar, Cross Ref

  7. Fuhler GM. The immune system and microbiome in pregnancy. Best Pract Res Clin Gastroenterol. 2020;44:101671.

    8. Indexed at, Google Scholar, Cross Ref

  8. Morelli AE, Sadovsky Y. Extracellular vesicles and immune response during pregnancy: A balancing act. Immunol Rev. 2022;308(1):105-22.

    9. Indexed at, Google Scholar, Cross Ref

  9. Gonzalez CA, Gonzalez S. Fetal and neonatal allo-immune response. Transfus Apher Sci. 2020;59(5):102945.

    10. Indexed at, Google Scholar, Cross Ref

  10. Yousefzadeh Y, Soltani-Zangbar MS, Hemmatzadeh M, et al. Fetomaternal immune tolerance: crucial mechanisms of tolerance for successful pregnancy in humans. Immunol Invest. 2022;51(4):1108-25.

    11. Indexed at, Google Scholar, Cross Ref

Get the App